1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Peritoneal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Langer, JC; Liebman, SM; Monk, PK; Pelletier, GJ | 1 |
| Cevikel, MH; Kozaci, LD; Ozgün, H; Sakarya, S | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Peritoneal Diseases
| Article | Year |
|---|---|
Mast cell mediators and peritoneal adhesion formation in the rat.
Topics: Animals; Azepines; Disease Models, Animal; Histamine Antagonists; Leukotriene D4; Male; Mast Cells; Methysergide; Ondansetron; Peritoneal Diseases; Platelet Activating Factor; Propionates; Pyrilamine; Quinolines; Ranitidine; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Tissue Adhesions; Triazoles | 1995 |
Lexipafant inhibits postsurgical adhesion formation.
Topics: Animals; Female; Hydroxyproline; Imidazoles; Interleukin-6; Leucine; Peritoneal Diseases; Platelet Activating Factor; Postoperative Complications; Rats; Rats, Wistar; Tissue Adhesions; Uterus; Wound Healing | 2002 |